Additionally, cGAMP induces an increase in PD-L1 expression on the tumor cell surface, increasing the response rate of anti-PD-L1 Nb, thereby blocking the immune escape pathway of PD-1/PD-L1. Here, PDCD1 is linked to neoplasm.